Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based survey.

This study demonstrates that Sub-Saharan Africa has substantial potential in neuro-oncology care practice capacity and facilities.

The most significant gaps were in neuropathology and molecular testing, which makes widespread implementation of the WHO 2021 diagnosis challenging.

Understanding the prevalence of central nervous system tumor subtypes in Sub-Saharan Africa is difficult due to the low number of brain tumor registries and biobanks.